Washington Trust’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Buy
3,719
+418
+13% +$27.5K 0.01% 275
2026
Q1
$235K Buy
3,301
+288
+10% +$22.7K 0.01% 264
2025
Q4
$247K Hold
3,013
0.01% 257
2025
Q3
$226K Buy
+3,013
New +$225K 0.01% 264
2025
Q2
Sell
-1,594
Closed -$129K 429
2025
Q1
$129K Sell
1,594
-576
-27% -$49.5K ﹤0.01% 294
2024
Q4
$170K Sell
2,170
-115
-5% -$9.78K 0.01% 285
2024
Q3
$214K Sell
2,285
-8
-0.3% -$671 0.01% 278
2024
Q2
$179K Buy
2,293
+440
+24% +$35.9K 0.01% 289
2024
Q1
$168K Buy
1,853
+133
+8% +$11.1K 0.01% 293
2023
Q4
$133K Sell
1,720
-18
-1% -$1.26K 0.01% 300
2023
Q3
$118K Hold
1,738
0.01% 289
2023
Q2
$141K Sell
1,738
-56
-3% -$4.47K 0.01% 284
2023
Q1
$147K Buy
+1,794
New +$128K 0.01% 282

Other funds holding GEHC

Washington Trust's GEHC Position: Q2 2026 in Review

Washington Trust increased its GE HealthCare (GEHC) stake by 13% in Q2 2026, buying an estimated $27.5K and bringing the position to 3,719 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #275.

Washington Trust first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $247K in Q4 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Washington Trust held 3,719 shares of GE HealthCare worth $238K as of Q2 2026.
  • Washington Trust bought 418 GE HealthCare shares in Q2 2026, an estimated $27.5K.
  • GE HealthCare made up 0.01% of Washington Trust's portfolio in Q2 2026, its #275 holding.
  • Washington Trust first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Washington Trust's GE HealthCare position peaked at $247K in Q4 2025.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Washington Trust's 13F filing for Q2 2026, filed 3 Aug 2026.